Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2548
http://purl.obolibrary.org/obo/NCIT_C2548
|
|---|---|
| Preferred Name | Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024 |
| Definitions |
A genetically-engineered protein formed by the fusion of prostatic acid phosphatase (PAP) and sargramostim (GM-CSF). Vaccination with antigen-presenting cells (APC) loaded with prostatic acid phosphatase-sargramostim fusion protein may elicit a cytotoxic T-cell response against tumor cells that express PAP. (NCI05)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A genetically-engineered protein formed by the fusion of prostatic acid phosphatase (PAP) and sargramostim (GM-CSF). Vaccination with antigen-presenting cells (APC) loaded with prostatic acid phosphatase-sargramostim fusion protein may elicit a cytotoxic T-cell response against tumor cells that express PAP. (NCI05) |
|---|---|
| prefLabel | Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024
|
| label | Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024
|
| PDQ_Closed_Trial_Search_ID | 38040
|
| code | C2548
|
| Has_Target | |
| prefixIRI | NCIT:C2548
|
| in_subset |
See more
See less
|
| Display_Name | Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024
|
| Preferred_Name | Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024
|
| FDA_UNII_Code | N5E5Q8249O
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024
|
| NCI_Drug_Dictionary_ID | 38040
|
| Legacy Concept Name | Prostatic_Acid_Phosphatase-Sargramostim_Fusion_Protein
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 38040
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0879585
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |